RADX

Radiopharm Theranostics Ltd

• NASDAQ·19h ago

  Radiopharm Theranostics Reports Positive Phase 1 Imaging Data For RAD 301 In Pancreatic Cancer

• TipRanks·20h ago

  Radiopharm announces data from imaging trial of RAD 301

• Benzinga·20h ago

  Radiopharm Theranostics Shares Data From Phase 1 Imaging Trial of RAD 301 In Healthy Volunteers And Subjects With Pancreatic Ductal Adenocarcinoma

• TipRanks·08/28 12:27

  Radiopharm Theranostics Posts Deeper FY26 Loss as R&D Spend Jumps and Cash Reserves Fall

• NASDAQ·08/26 11:41

  Radiopharm Doses First Patient In Second Cohort Of Phase 1/2a RV-01 Trial

• TipRanks·08/26 11:15

  Radiopharm doses first patient in second cohort of RV-01 trial

• Benzinga·08/26 11:09

  Radiopharm Doses First Patient In Second Cohort Of Its First-In-Human Phase 1/2a Clinical Trial Of RV-01 In Patients With B7-H3 Expressing Tumors

• Benzinga·08/24 12:06

  12 Health Care Stocks Moving In Monday's Pre-Market Session

• NASDAQ·08/20 11:55

  Radiopharm Advances RAD202 Phase 1 Trial To Higher 180mCi Dose Level

• NASDAQ·08/17 13:24

  Radiopharm Theranostics To Meet FDA On Phase 3 Design For RAD101; Phase 2b Shows 93% MRI Concordance

• TipRanks·08/17 11:40

  Radiopharm schedules End-of-Phase 2 meeting with FDA for RAD101

• Benzinga·08/17 11:36

  Radiopharm Theranostics Schedules An FDA End-Of-Phase 2 For October 1, 2026, To Align On The Design Of A Pivotal Phase 3 Trial To Evaluate RAD101 In Patients With Suspected Recurrence Of Brain Metastases Following Radiotherapy

• Benzinga·08/07 21:05

  12 Health Care Stocks Moving In Friday's After-Market Session

• Benzinga·07/29 12:05

  12 Health Care Stocks Moving In Wednesday's Pre-Market Session

• TipRanks·07/28 16:27

  Radiopharm Theranostics Secures Multimillion-Dollar Financings to Advance Oncology Radiopharmaceutical Pipeline